| ADPKD Group Counts (%)/ Mean ± SD (median (p5, p95)) | RRT-treated Counts (%)/ Mean ± SD (median (p5, p95)) | Non RRT-treated Counts (%)/ Mean ± SD (median (p5, p95)) | P-value |
---|---|---|---|---|
N | 6142 | 1452 (23.6) | 4690 (76.4) | Â |
Sex |  < .001 | |||
 Male | 3169 (51.6) | 806 (55.5) | 2363 (50.4) |  |
 Female | 2973 (48.4) | 646 (44.5) | 2327 (49.6) |  |
Age |  < .001 | |||
 20—39 | 1617 (26.3) | 166 (11.4) | 1451 (30.9) |  |
 40—59 | 2752 (44.8) | 731 (50.3) | 2021 (43.1) |  |
  ≥ 60 | 1773 (28.9) | 555 (38.2) | 1218 (26.0) |  |
Age (years) at initiation of RRT | - | 59.2 ± 13.4 58 (39, 82) | - |  |
Comorbidities | Â | |||
 Hypertension (HTN) | 3951 (64.3) | 1245 (85.7) | 2706 (57.7) |  < .001 |
 Dyslipidemia (DLP) | 1476 (24.0) | 417 (28.7) | 1059 (22.6) |  < .001 |
 Diabetes Mellitus (DM) | 786 (12.8) | 252 (17.4) | 534 (11.4) |  < .001 |
Combinations of HTN, DLP, and DM |  < .001 | |||
 HTN ( +) DLP (-) DM (-) | 2372 (38.6) | 737 (50.8) | 1635 (34.9) |  |
 HTN (-) DLP ( +) DM (-) | 143 (2.33) | 9 (0.62) | 134 (2.86) |  |
 HTN (-) DLP (-) DM ( +) | 65 (1.06) | 15 (1.03) | 50 (1.07) |  |
 HTN ( +) DLP ( +) DM (-) | 891 (14.5) | 274 (18.9) | 617 (13.2) |  |
 HTN ( +) DLP (-) DM ( +) | 279 (4.54) | 103 (7.09) | 176 (3.75) |  |
 HTN (-) DLP ( +) DM ( +) | 33 (0.54) | 3 (0.21) | 30 (0.64) |  |
 HTN ( +) DLP ( +) DM ( +) | 409 (6.66) | 131 (9.02) | 278 (5.93) |  |
 HTN (-) DLP (-) DM (-) | 1950 (31.8) | 180 (12.4) | 1770 (37.7) |  |
Drug History | ||||
 Metformin | 70 (1.14) | 11 (0.76) | 59 (1.26) | 0.117 |
 NSAIDs | 373 (6.07) | 48 (3.31) | 325 (6.93) |  < .001 |
Duration of follow-up (months) | ||||
 From ADPKD diagnosis to RRT or censor datea | 73.82 ± 54.02 64.69 (3.32, 171.99) | 40.94 ± 40.59 26.84 (0.99, 129.58) | 84.00 ± 53.60 79.41 (6.74, 176.18) |  < .001 |
 From ADPKD diagnosis to death or censor datea | 77.97 ± 52.73 71.47 (5.22, 173.0) | 91.85 ± 52.11 89.54 (12.04, 180.5) | 73.67 ± 52.18 65.38 (4.14, 169.5) |  < .001 |
 From RRT to death or censor datea | - | 50.91 ± 44.45 39.70 (1.08, 138.1) | - |  |
Death | 1315 (21.4) | 609 (41.9) | 706 (15.1) | Â |
 Mortality Rateb | 2.33 | 3.59 | 1.79 |  |